1. Search Result
Search Result
Results for "

UDP

" in MedChemExpress (MCE) Product Catalog:

91

Inhibitors & Agonists

7

Biochemical Assay Reagents

3

Peptides

31

Natural
Products

10

Recombinant Proteins

4

Isotope-Labeled Compounds

1

Antibodies

2

Click Chemistry

1

Oligonucleotides

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-145934

    UDP-N-azidoacetylgalactosamine disodium

    Biochemical Assay Reagents Metabolic Disease
    UDP-GalNAz disodium (UDP-N-azidoacetylgalactosamine disodium) is the analogue of UDP-GalNAc. UDP-GalNAc is the donor substrate of many N-acetylgalactosaminyltransferases, enzymes which transfer GalNAc from the nucleotide sugar to a saccharide or peptide acceptor . UDP-GalNAz (disodium) is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
    UDP-GalNAz disodium
  • HY-E70020

    Others Others
    UDP-Glc dehydrogenase (UGDH) catalyzes is a NAD+-dependent enzyme that catalyzes the two-fold oxidation of UDP-glucose (UDP-Glc) to produce UDP-glucuronic acid. UDP-Glc dehydrogenase (UGDH) is a key enzyme in the nucleotide-sugar interconversion pathway necessary for biosynthesis of many cell-wall polysaccharides .
    UDP-Glc dehydrogenase (UGDH)
  • HY-112174
    UDP-GlcNAc disodium
    5 Publications Verification

    UDP-α-D-N-Acetylglucosamine disodium

    OGT Metabolic Disease
    UDP-GlcNAc Disodium Salt (UDP-α-D-N-Acetylglucosamine Disodium Salt) is a donor substrate of O-GlcNAc transferase (OGT).
    UDP-GlcNAc disodium
  • HY-145934A

    OGT Biochemical Assay Reagents Glycosidase p62 Metabolic Disease
    UDP-GlcNAz disodium is a sugar donor. UDP-GlcNAz disodium serves as a substrate for OGTase and O-GlcNAcase. UDP-GlcNAz disodium can glycosylate p62 and its glycosidic bond can be cleaved by O-GlcNAcase through catalysis. UDP-GlcNAz disodium can be used in the research of related protein glycosylation .
    UDP-GlcNAz disodium
  • HY-N10573
    UDP-rhamnose
    1 Publications Verification

    Endogenous Metabolite Others
    UDP-rhamnose is one of the substrates for pectin synthesis in cell wall. UDP-rhamnose can be identified in fungi, it is one of the most common sugar donor in plants .
    UDP-rhamnose
  • HY-114365

    UDP-N-acetyl-D-galactosamine disodium

    Endogenous Metabolite Metabolic Disease
    UDP-GalNAc (UDP-N-acetyl-D-galactosamine) disodium is a sugar nucleotide and a substrate of EpsC115. EpsC115 is an exopolymeric substances (EPS) N-terminal deletion mutant with the residue 1-115 deletion. UDP-GalNAc UDP-GalNAc is the donor substrate of many N-acetylgalactosaminyltransferases, enzymes which transfer GalNAc from the nucleotide sugar to a saccharide or peptide acceptor .
    UDP-GalNAc disodium
  • HY-137608

    UDP-β-S

    P2Y Receptor Cardiovascular Disease
    Uridine 5'-O-thiodiphosphate (UDP-β-S) is a stable analog of UDP. As a selective agonist of P2Y6 receptor, Uridine 5'-O-thiodiphosphate has higher metabolic stability and can be used in the study of cardiovascular diseases .
    Uridine 5'-O-thiodiphosphate
  • HY-125954B

    Biochemical Assay Reagents Metabolic Disease
    UDP-galacturonic acid trisodium is a cofactor that is formed by the catalytic activity of UDP-glucose dehydrogenase .
    UDP-galacturonic acid trisodium
  • HY-E70028

    Endogenous Metabolite Metabolic Disease
    UDP-sugar pyrophosphorylase (BlUSP) is the enzyme capable of activating glucose-1-phosphate (Glc-1-P) to UDP-glucose (UDP-Glc). UDP-sugar pyrophosphorylase (BlUSP) catalyzes a reversible transfer of the uridyl group from UTP to sugar-1-phosphate, producing UDP-sugar and pyrophosphate (PPi) .
    UDP-sugar pyrophosphorylase (BlUSP)
  • HY-N8515

    UDP-3-O-(3-hydroxytetradecanoyl)-N-acetylglucosamine

    Endogenous Metabolite Infection
    UDP-3-O-acyl-GlcNAc (UDP-3-O-(3-hydroxytetradecanoyl)-N-acetylglucosamine) is an E. coli metabolite that is involved in 3-deoxy-D-manno-octulosonate (KDO) biosynthesis pathway .
    UDP-3-O-acyl-GlcNAc
  • HY-E70021

    Others Others
    UDP-Glc 4-epimerase (GalE) is catalytically active enzyme. UDP-Glc 4-epimerase (GalE) catalyzes the reversible conversion of abundantly available UDP-glucose to UDP-galactose .
    UDP-Glc 4-epimerase (GalE)
  • HY-139793

    OGT Endogenous Metabolite Metabolic Disease
    UDP-glucosamine (UDP-GlcNAc) disodium is a substrate for O-GlcNAc transferase, which catalyzes the attachment of O-GlcNAc to proteins. O-GlcNAcase catalyzes the removal of O-GlcNAc from proteins. UDP-glucosamine (UDP-GlcNAc) disodium is the end product of the hexosamine biosynthesis pathway, which is regulated primarily by glucose-6-phosphate-Glutamine:fructose-6-phosphate amidotransferase (GFAT) .
    UDP-glucosamine disodium
  • HY-E70066

    Others Others
    UDP-sugar pyrophosphorylase (AtUSP) is a broad substrate enzyme that synthesizes nucleotide sugars. UDP-sugar pyrophosphorylase catalyzes the conversion of various monosaccharide 1-phosphates to the respective UDP-sugars in the salvage pathway .
    UDP-sugar pyrophosphorylase (AtUSP)
  • HY-137261

    Others Metabolic Disease
    UDP-β-D-glucose disodium is a the stereoisomer of UDP-α-D-glucose. UDP-β-D-glucose disodium is an oligosaccharide that can be used to synthesize glycoproteins and glycolipids. UDP-β-D-glucose disodium can be used as a substrate .
    UDP-β-D-glucose disodium
  • HY-N11287

    Endogenous Metabolite Others
    UDP-xylose is a natural product that could be isolated from Cryptococcus laurentii (NRRL Y-1401). UDP-xylose is a sugar donor for the synthesis of glycoproteins, polysaccharides, various metabolites, and oligosaccharides in plants, vertebrates, and fungi .
    UDP-xylose
  • HY-W585865

    UDP-3-O-(3-hydroxytetradecanoyl)-N-acetylglucosamine Tris

    Endogenous Metabolite Infection
    UDP-3-O-acyl-GlcNAc (UDP-3-O-(3-hydroxytetradecanoyl)-N-acetylglucosamine) Tris is an E. coli metabolite that is involved in 3-deoxy-D-manno-octulosonate (KDO) biosynthesis pathway .
    UDP-3-O-acyl-GlcNAc Tris
  • HY-N8515C

    UDP-3-O-(3-hydroxytetradecanoyl)-N-acetylglucosamine disodium

    Endogenous Metabolite Infection Others
    UDP-3-O-acyl-GlcNAc (UDP-3-O-(3-hydroxytetradecanoyl)-N-acetylglucosamine) disodium is an E. coli metabolite that is involved in 3-deoxy-D-manno-octulosonate (KDO) biosynthesis pathway .
    UDP-3-O-acyl-GlcNAc disodium
  • HY-112174S

    UDP-α-D-N-Acetylglucosamine-13C disodium

    Isotope-Labeled Compounds Metabolic Disease
    UDP-GlcNAc- 13C (disodium) is the 13C labeled UDP-GlcNAc Disodium Salt. UDP-GlcNAc Disodium Salt (UDP-α-D-N-Acetylglucosamine Disodium Salt) is a donor substrate of O-GlcNAc transferase (O[1][2].
    UDP-GlcNAc-13C disodium
  • HY-150524

    Endogenous Metabolite P2Y Receptor Metabolic Disease
    UDP-Galactose is a monosaccharide involved in nucleotide sugar metabolism. UDP-Galactose and its derivatives act as a natural agonist for Gi protein-conjugated P2Y14 receptors in the immune system (IC50=0.67 μM, hP2Y14) .
    UDP-Galactose
  • HY-170876

    UDP-4-keto-xylose

    Bacterial Infection
    UX4O is an allosteric inhibitor of UDP-glucose dehydrogenase UGDH. hUGDH is a hexamer that can catalyze the oxidation of UDP-glucose to UDP-glucuronic acid. hUGDH has an active (E) state and an inactive (EΩ) state, and it needs to bind to the allosteric inhibitor UDP-xylose (UDP-Xyl) to be stabilized in the inactive state. And UX4O may also be a physiologically relevant inhibitor of allosteric UGDH in bacteria that do not produce UDP-Xyl .
    UX4O
  • HY-N7033R

    Drug Intermediate Metabolic Disease
    UDP-glucuronic acid (trisodium) (Standard) is the analytical standard of UDP-glucuronic acid (trisodium). This product is intended for research and analytical applications. UDP-?glucuronic acid trisodium (Uridine-5'-diphosphoglucuronic acid trisodium salt) is a critical precursor for essential glycoconjugates across biological kingdoms, ranging from mammalian glycosaminoglycans and plant cell wall polysaccharides to bacterial capsule glycoglycerolipids.
    UDP-glucuronic acid (trisodium) (Standard)
  • HY-114364

    P2Y Receptor Endogenous Metabolite Infection Neurological Disease Metabolic Disease
    UDP-Galactose disodium is a natural agonist of the P2Y14 receptor with an EC50 of 0.67 μM for the hP2Y14 receptor. UDP-Galactose disodium is a substrate for the transferase beta-1, 4 galactosyltransferase V (B4GALT5). In addition, UDP-Galactose disodium is required for the biosynthesis of several abundant glycoconjugates that form the surface glycocalyx of Leishmania major .
    UDP-Galactose disodium
  • HY-N11287A

    Endogenous Metabolite Others
    UDP-xylose disodium is a natural product that could be isolated from Cryptococcus laurentii (N RRL Y-1401). UDP-xylose disodium is a sugar donor for the synthesis of glycoproteins, polysaccharides, various metabolites, and oligosaccharides in plants, vertebrates, and fungi ..
    UDP-xylose disodium
  • HY-125954

    UDP-α-D-glucuronic acid

    Endogenous Metabolite Metabolic Disease
    Uridine diphosphate glucuronic acid (UDP-α-D-glucuronic acid) is a cofactor that is formed by the catalytic activity of UDP-glucose dehydrogenase. Uridine diphosphate glucuronic acid is a central precursor in sugar nucleotide biosynthesis and common substrate for C4-epimerases and decarboxylases releasing UDP-galacturonic acid (UDP-GalA) and UDP-pentose products, respectively. Uridine diphosphate glucuronic acid as a glucuronic acid donor, can be used for for the research of the conjugation of bilirubin in the endoplasmic recticulum .
    Uridine diphosphate glucuronic acid
  • HY-N8515B

    UDP-3-O-(3-hydroxytetradecanoyl)-N-acetylglucosamine diammonium

    Endogenous Metabolite Others
    UDP-3-O-acyl-GlcNAc diammonium is an E. coli metabolite that is involved in 3-deoxy-D-manno-octulosonate (KDO) biosynthesis pathway .
    UDP-3-O-acyl-GlcNAc diammonium
  • HY-114364S

    Isotope-Labeled Compounds Others
    UDP-α-D-Galactose- 13C (disodium) is the 13C labeled UDP-α-D-Galactose disodium salt[1].
    UDP-α-D-Galactose-13C disodium
  • HY-141851

    Biochemical Assay Reagents Others
    UDP-glucose dehydrogenase is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
    UDP-glucose dehydrogenase
  • HY-125954A

    UDP-α-D-glucuronic acid ammonium

    Endogenous Metabolite Metabolic Disease
    Uridine diphosphate glucuronic acid (UDP-GlcA) ammonium is a cofactor that is formed by the catalytic activity of UDP-glucose dehydrogenase. Uridine diphosphate glucuronic acid (ammonium) is a central precursor in sugar nucleotide biosynthesis and common substrate for C4-epimerases and decarboxylases releasing UDP-galacturonic acid (UDP-GalA) and UDP-pentose products, respectively. Uridine diphosphate glucuronic acid (ammonium), as a glucuronic acid donor, can be used for for the research of the conjugation of bilirubin in the endoplasmic recticulum .
    Uridine diphosphate glucuronic acid ammonium
  • HY-164903

    Biochemical Assay Reagents Others
    UDP-D-GalNAlk disodium is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
    UDP-D-GalNAlk
  • HY-164903A

    Biochemical Assay Reagents Others
    UDP-D-GalNAlk disodium is a biochemical reagent that can be used as a biological material or organic compound for life science related research .
    UDP-D-GalNAlk disodium
  • HY-E70423

    Biochemical Assay Reagents Others
    UDP-glucuronic acid decarboxylase is a decarboxylase. Enzymes have high catalytic efficiency, high specificity, and mild operating conditions. It can be applied in industries such as pharmaceuticals, industrial production, food manufacturing, and aquaculture .
    UDP-glucuronic acid decarboxylase
  • HY-N7033

    Uridine 5'-diphosphoglucuronic acid trisodium salt

    Drug Intermediate Metabolic Disease
    UDP-​glucuronic acid trisodium (Uridine-5'-diphosphoglucuronic acid trisodium salt) is a critical precursor for essential glycoconjugates across biological kingdoms, ranging from mammalian glycosaminoglycans and plant cell wall polysaccharides to bacterial capsule glycoglycerolipids.
    UDP-glucuronic acid trisodium
  • HY-E70447

    Biochemical Assay Reagents Others
    UDP-4-Keto-6-deoxy-D-glucose 3,5-epimerase/4-reductase (ApmUGER) is an epimerase/reductase. Enzymes have high catalytic efficiency, high specificity, and mild operating conditions. It can be applied in industries such as pharmaceuticals, industrial production, food manufacturing, and aquaculture .
    UDP-4-Keto-6-deoxy-D-glucose 3,5-epimerase/4-reductase (ApmUGER)
  • HY-N7032S

    UDP-D-Glucose-13C disodium

    Isotope-Labeled Compounds Endogenous Metabolite P2Y Receptor Neurological Disease
    Uridine 5′-diphosphoglucose- 13C (disodium) is the 13C labeled Uridine 5′-diphosphoglucose disodium salt. Uridine 5′-diphosphoglucose disodium salt (UDP-D-Glucose disodium salt) is the precursor of glucose-containing oligosaccharides, polysaccharides, glycop
    Uridine 5′-diphosphoglucose-13C disodium
  • HY-E70139

    EC:2.4.1.313; B3GALNT2; β-1,3-N-acetylgalactosaminyltransferase II

    Glucosylceramide Synthase (GCS) Others
    UDP-GalNAc:β-1,3-N-acetylgalactosaminyltransferase 2 ( EC:2.4.1.313; B3GALNT2; β-1,3-N-acetylgalactosaminyltransferase II) is a glycosyltransferase .
    UDP-GalNAc:β-1,3-N-acetylgalactosaminyltransferase 2
  • HY-N7032

    UDP-D-Glucose disodium salt

    Endogenous Metabolite P2Y Receptor Cardiovascular Disease Metabolic Disease Inflammation/Immunology
    Uridine 5’-diphosphoglucose (UDP-glucose) disodium salt, secreted by cardiomyocytes during ischemia and reperfu, is a potent agonist of the proinflammatory P2Y14 receptor. It acts an important role in the regulation of inflammation and neutrophil polarization in neutrophils. Uridine 5’-diphosphoglucose disodium salt is also the precursor of glucose-containing oligosaccharides, polysaccharides, glycoproteins, and glycolipids in animal tissues and in some microorganisms. Uridine 5’-diphosphoglucose disodium salt is promising for research in counteracting myocardial infarction/reperfusion (MIR)-induced inflammation in the heart tissue .
    Uridine 5′-diphosphoglucose disodium salt
  • HY-N7032S1

    UDP-D-Glucose-13C6 disodium

    P2Y Receptor Endogenous Metabolite Neurological Disease
    Uridine 5′-diphosphoglucose- 13C6 (disodium) is the 13C labeled Uridine 5′-diphosphoglucose disodium salt[1]. Uridine 5′-diphosphoglucose disodium salt (UDP-D-Glucose disodium salt) is the precursor of glucose-containing oligosaccharides, polysaccharides, glycoproteins, and glycolipids in animal tissues and in some microorganisms. Uridine-5′-diphosphoglucose is an agonist of the P2Y14 receptor, a neuroimmune system GPCR[2].
    Uridine 5′-diphosphoglucose-13C6 disodium
  • HY-154828

    3′,5′-UDP

    DNA/RNA Synthesis Others
    Uridine 3′,5′-diphosphate (3′,5′-UDP; Compound pUp) is a competitive RNase inhibitor .
    Uridine 3′,5′-diphosphate
  • HY-N7390

    Endogenous Metabolite Metabolic Disease
    Cholesterol glucuronide is an endogenous metabolite of lipid generated in the liver by UDP glucuonyltransferase .
    Cholesterol glucuronide
  • HY-108663

    5-Methoxyuridine 5'-trihydrogen diphosphate

    P2Y Receptor Neurological Disease Metabolic Disease
    5-OMe-UDP (5-methoxyuridine 5'-trihydrogen diphosphate) is a P2Y6 receptor agonist (EC50=0.08 μM). 5-OMe-UDP activates the P2Y6 receptor by binding to it, which triggers signaling pathways within the cell. This activation can lead to an increase in intracellular calcium ion concentration, which in turn regulates cellular function. The methoxy groups of 5-OMe-UDP provide additional activity and selectivity, contributing to the binding of 5-OMe-UDP to the P2Y6 receptor. 5-OMe-UDP can be used to study diseases related to P2Y6 receptor function, such as diabetes, inflammatory bowel disease, Alzheimer's disease, etc .
    5-OMe-UDP
  • HY-156905

    Biochemical Assay Reagents Cancer
    6-Azido-N-acetylgalactosamine-UDP (compound 5) is an active sugar donor in the beta-1, 3-N-Acetylhexaminyltransferase (LgtA)-catalyzed glycosylation of lactose .
    6-Azido-N-acetylgalactosamine-UDP
  • HY-110369

    a,β-Methylene-2-thio-UDP trisodium

    P2Y Receptor Inflammation/Immunology
    MRS2905 (α,β-Methylene-2-thio-UDP) trisodium is a selective P2Y14R agonist with an EC50 of 0.92 nM. MRS2905 trisodium is inactive at the UDP-activated P2Y6 receptor, and at other P2Y receptors .
    MRS2905 trisodium
  • HY-130836

    Bacterial Infection
    LpxH-IN-AZ1, a sulfonyl piperazine compound, is a potent UDP-2,3-diacylglucosamine pyrophosphate hydrolase LpxH inhibitor. LpxH-IN-AZ1 is a potent inhibitor of Klebsiella pneumoniae LpxH with IC50 of 0.36 μM .
    LpxH-IN-AZ1
  • HY-130838

    Bacterial Infection
    JH-LPH-33, a sulfonyl piperazine analog, is a potent UDP-2,3-diacylglucosamine pyrophosphate hydrolase LpxH inhibitor. JH-LPH-33 displays outstanding antibiotic activity with a MIC value of 0.66 μg/mL .
    JH-LPH-33
  • HY-130837

    Bacterial Infection
    JH-LPH-28, a sulfonyl piperazine analog, is a potent UDP-2,3-diacylglucosamine pyrophosphate hydrolase LpxH inhibitor. JH-LPH-28 displays outstanding antibiotic activity with a MIC value of 0.83 μg/mL .
    JH-LPH-28
  • HY-P2134

    Biochemical Assay Reagents Metabolic Disease
    YSDSPSTST is a receptor substrate of UDP-N-acetylglucosamine:peptide N-acetylglucosaminyltransferase .
    YSDSPSTST
  • HY-B0811
    Salicylamide
    1 Publications Verification

    2-Hydroxybenzamide

    UGT Inflammation/Immunology
    Salicylamide is an inhibitor of microsomal UDP-glucuronosyltransferase. Salicylamide is an analgesic and anti-pyretic agent.
    Salicylamide
  • HY-114737

    Bacterial Infection
    L-573655 is a reversible inhibitor of UDP-3-O-[R-3-hydroxymyristoyl]-GlcNAc deacetylase with an IC50 value of 8.5 μM. L-573655 possesses antibacterial activity against a wild-type strain of E. coli. with MIC values of 200-400 μg/mL .
    L-573655
  • HY-100319

    UGT Metabolic Disease
    UK-157147 is a substrate for UDP-glucuronosyltransferases (UGT1A1) with a Km value of 105 μM.
    UK-157147
  • HY-N0859

    Schizanhenol; Gomisin-K3

    UGT Cancer
    Schisanhenol is a natural compound solated from Schisandra rubriflora; UGT2B7 UDP-glucuronosyltransferases inhibitor.
    Schisanhenol

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: